中文 | English
Return
Total: 156 , 1/16
Show Home Prev Next End page: GO
Author:( Haiqing ZHANG)

1.Low-dose defibrotide in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: A case report

Haiqing GUO ; Haiqing SUN ; Jing ZHANG ; Lixia QIU

Journal of Clinical Hepatology 2026;42(4):918-922

2.Prognostic value of CT combined with DCE-MRI parameters in predicting poor short-term prognosis of patients with colorectal cancer after radical surgery

Ning ZHANG ; Yong WANG ; Xiaoyu GAO ; Lin WANG ; Haiqing YANG ; Yinghao HAO

Chinese Journal of Endocrine Surgery 2025;19(2):271-275

3.Modified Shengxian Decoction modulates PI3K/AKT-mediated inflammatory response in COPD through the lung-intestinal axis

Yanrui WU ; Chunyan YANG ; Yanqiong WANG ; Haiqing JING ; Jiayi SONG ; Jianmei LI ; Juntu ZHANG

Journal of Xi'an Jiaotong University(Medical Sciences) 2025;46(2):323-332

4.Study on patterns of traditional Chinese medicine syndrome changes in mouse models of chronic psychological stress

Qianyin XUE ; Shuya WU ; Jingyu XU ; Yi ZHANG ; Mingjia ZHANG ; Haiqing AO

Acta Laboratorium Animalis Scientia Sinica 2025;33(2):180-189

5.Investigation of the Mechanism of Action of Qinggan Yipi Formula in the Inhibition of Hepatic Fibrosis Based on Network Pharmacology and Experiments

Haiqing LIU ; Wenjing XUE ; Jiaqi LOU ; Siqi WANG ; Lurong ZHANG ; Junping CHENG

World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(8):2418-2430

6.Prognostic value of CT combined with DCE-MRI parameters in predicting poor short-term prognosis of patients with colorectal cancer after radical surgery

Ning ZHANG ; Yong WANG ; Xiaoyu GAO ; Lin WANG ; Haiqing YANG ; Yinghao HAO

Chinese Journal of Endocrine Surgery 2025;19(2):271-275

7.Application and evaluation of animal model of chronic psychological stress modeling methods in the combination of disease and syndrome

Qianyin XUE ; Shuya WU ; Jingyu XU ; Buping LIU ; Yi ZHANG ; Mingjia ZHANG ; Haiqing AO

Acta Laboratorium Animalis Scientia Sinica 2025;33(6):893-904

8.Influence factors for the development and regression of metabolic dysfunction-associated fatty liver disease:A study based on the health check-up population in Beijing,China

Haiqing GUO ; Xiaohui LIU ; Mingliang LI ; Feng LIU ; Yali LIU ; Jing ZHANG

Journal of Clinical Hepatology 2025;41(7):1319-1326

9.Influence factors for the development and regression of metabolic dysfunction-associated fatty liver disease:A study based on the health check-up population in Beijing,China

Haiqing GUO ; Xiaohui LIU ; Mingliang LI ; Feng LIU ; Yali LIU ; Jing ZHANG

Journal of Clinical Hepatology 2025;41(7):1319-1326

10.Investigation of the Mechanism of Action of Qinggan Yipi Formula in the Inhibition of Hepatic Fibrosis Based on Network Pharmacology and Experiments

Haiqing LIU ; Wenjing XUE ; Jiaqi LOU ; Siqi WANG ; Lurong ZHANG ; Junping CHENG

World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(8):2418-2430

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 156 , 1/16 Show Home Prev Next End page: GO